GUERBET (GBT.PA) Fundamental Analysis & Valuation

EPA:GBT • FR0000032526

12.22 EUR
-0.34 (-2.71%)
Last: Mar 11, 2026, 07:00 PM

This GBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, GBT scores 4 out of 10 in our fundamental rating. GBT was compared to 65 industry peers in the Health Care Equipment & Supplies industry. While GBT seems to be doing ok healthwise, there are quite some concerns on its profitability. GBT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. GBT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year GBT was profitable.
  • In the past year GBT had a positive cash flow from operations.
  • GBT had positive earnings in 4 of the past 5 years.
  • In the past 5 years GBT always reported a positive cash flow from operatings.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • GBT has a worse Return On Assets (0.76%) than 63.08% of its industry peers.
  • With a Return On Equity value of 2.06%, GBT is not doing good in the industry: 63.08% of the companies in the same industry are doing better.
  • GBT has a worse Return On Invested Capital (3.15%) than 64.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GBT is significantly below the industry average of 10.72%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.15%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.96%, GBT is doing worse than 63.08% of the companies in the same industry.
  • GBT's Profit Margin has declined in the last couple of years.
  • GBT's Operating Margin of 4.19% is on the low side compared to the rest of the industry. GBT is outperformed by 64.62% of its industry peers.
  • In the last couple of years the Operating Margin of GBT has declined.
  • With an excellent Gross Margin value of 78.03%, GBT belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. GBT.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
  • Compared to 1 year ago, GBT has about the same amount of shares outstanding.
  • GBT has more shares outstanding than it did 5 years ago.
  • GBT has a worse debt/assets ratio than last year.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • GBT has an Altman-Z score of 2.04. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GBT's Altman-Z score of 2.04 is in line compared to the rest of the industry. GBT outperforms 41.54% of its industry peers.
  • GBT has a debt to FCF ratio of 8.94. This is a slightly negative value and a sign of low solvency as GBT would need 8.94 years to pay back of all of its debts.
  • GBT's Debt to FCF ratio of 8.94 is in line compared to the rest of the industry. GBT outperforms 43.08% of its industry peers.
  • A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.93, GBT is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Altman-Z 2.04
ROIC/WACC0.45
WACC6.92%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.32 indicates that GBT has no problem at all paying its short term obligations.
  • The Current ratio of GBT (2.32) is better than 69.23% of its industry peers.
  • A Quick Ratio of 1.03 indicates that GBT should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, GBT is in line with its industry, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. GBT.PA Growth Analysis

3.1 Past

  • The earnings per share for GBT have decreased strongly by -77.27% in the last year.
  • GBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.50% yearly.
  • Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
  • GBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

  • Based on estimates for the next years, GBT will show a decrease in Earnings Per Share. The EPS will decrease by -5.56% on average per year.
  • The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y-93.2%
EPS Next 2Y-45.63%
EPS Next 3Y-1.43%
EPS Next 5Y-5.56%
Revenue Next Year-6.58%
Revenue Next 2Y-5.33%
Revenue Next 3Y-1.8%
Revenue Next 5Y3.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

4

4. GBT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.37, GBT is valued on the expensive side.
  • GBT's Price/Earnings ratio is a bit cheaper when compared to the industry. GBT is cheaper than 80.00% of the companies in the same industry.
  • GBT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
  • The Forward Price/Earnings Ratio is negative for GBT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 20.37
Fwd PE N/A
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 96.92% of the companies are valued more expensively.
  • GBT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GBT is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.46
EV/EBITDA 3.73
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.63%
EPS Next 3Y-1.43%

4

5. GBT.PA Dividend Analysis

5.1 Amount

  • GBT has a Yearly Dividend Yield of 2.69%.
  • Compared to an average industry Dividend Yield of 1.01, GBT pays a better dividend. On top of this GBT pays more dividend than 87.69% of the companies listed in the same industry.
  • GBT's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

  • The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

  • GBT pays out 81.59% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of GBT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP81.59%
EPS Next 2Y-45.63%
EPS Next 3Y-1.43%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GBT.PA Fundamentals: All Metrics, Ratios and Statistics

GUERBET

EPA:GBT (3/11/2026, 7:00:00 PM)

12.22

-0.34 (-2.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23
Earnings (Next)03-11
Inst Owners9.29%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap154.46M
Revenue(TTM)809.67M
Net Income(TTM)7.73M
Analysts44
Price Target13.82 (13.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.59%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.23%
PT rev (3m)-11.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)85.72%
EPS NY rev (3m)-76.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.99%
Revenue NY rev (3m)-2.88%
Valuation
Industry RankSector Rank
PE 20.37
Fwd PE N/A
P/S 0.19
P/FCF 3.46
P/OCF 1.65
P/B 0.41
P/tB 0.56
EV/EBITDA 3.73
EPS(TTM)0.6
EY4.91%
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)3.53
FCFY28.86%
OCF(TTM)7.4
OCFY60.56%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.45%
ROIC 3.15%
ROICexc 3.64%
ROICexgc 4.3%
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.51%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Debt/EBITDA 3.27
Cap/Depr 66.71%
Cap/Sales 6.05%
Interest Coverage 1.56
Cash Conversion 87.13%
Profit Quality 576.4%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.04
F-Score5
WACC6.92%
ROIC/WACC0.45
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-93.2%
EPS Next 2Y-45.63%
EPS Next 3Y-1.43%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-6.58%
Revenue Next 2Y-5.33%
Revenue Next 3Y-1.8%
Revenue Next 5Y3.86%
EBIT growth 1Y-42.07%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year41.93%
EBIT Next 3Y21.64%
EBIT Next 5Y21.78%
FCF growth 1Y182.18%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2940.2%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the fundamental rating for GBT stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


What is the valuation status of GUERBET (GBT.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


What is the financial health of GUERBET (GBT.PA) stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


Is the dividend of GUERBET sustainable?

The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.59%.